메뉴 건너뛰기




Volumn 41, Issue 8, 2003, Pages 12-17

Pharmacological treatments for ADHD and the novel agent atomoxetine

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ATOMOXETINE; PROPYLAMINE;

EID: 0141764688     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (4)

References (34)
  • 4
    • 0036925632 scopus 로고    scopus 로고
    • Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder
    • Barkley, R.A. (2002). Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 63(Suppl. 12), 10-15.
    • (2002) Journal of Clinical Psychiatry , vol.63 , Issue.SUPPL. 12 , pp. 10-15
    • Barkley, R.A.1
  • 6
    • 0036638788 scopus 로고    scopus 로고
    • Driving in young adults with attention deficit hyperactivity disorder: Knowledge, performance, adverse outcomes and the role of executive functions
    • Barkley, R.A., Murphy, K.R., DuPaul, G.I., & Bush, T. (2002). Driving in young adults with attention deficit hyperactivity disorder: Knowledge, performance, adverse outcomes and the role of executive functions. Journal of International Neuropsychology Society, 8, 655-672.
    • (2002) Journal of International Neuropsychology Society , vol.8 , pp. 655-672
    • Barkley, R.A.1    Murphy, K.R.2    DuPaul, G.I.3    Bush, T.4
  • 7
    • 0024804130 scopus 로고    scopus 로고
    • Biederman, J., Baldessarini, R.J., Wright, V., Knee, D., Harmatz, J.S., & Goldblatt, A. (1989). A double-blind placebo controlled study of desipramine in the treatment ADD, II: Serum drug levels and cardiovascular findings. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 903-911.
    • Biederman, J., Baldessarini, R.J., Wright, V., Knee, D., Harmatz, J.S., & Goldblatt, A. (1989). A double-blind placebo controlled study of desipramine in the treatment ADD, II: Serum drug levels and cardiovascular findings. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 903-911.
  • 8
    • 0000925786 scopus 로고    scopus 로고
    • Anterior cingulated cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop
    • Bush, G., Frazier, J.A., Rauch, S.L., Seidmann, L.J., Whalen, P.J. Jenike, M.A., et al. (1999). Anterior cingulated cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biological Psychiatry, 45, 1542-1552.
    • (1999) Biological Psychiatry , vol.45 , pp. 1542-1552
    • Bush, G.1    Frazier, J.A.2    Rauch, S.L.3    Seidmann, L.J.4    Whalen, P.J.5    Jenike, M.A.6
  • 9
    • 0036848458 scopus 로고    scopus 로고
    • Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention-deficit/hyperactivity disorder
    • Bymaster, F.P., Katner, J.S., Nelson, D.L., Hemrick-Lueke, S.K., Threlkeld, P.G., Heiligenstein, J.H., et al. (2002). Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention-deficit/hyperactivity disorder. Neuropsychopharmacology, 27, 699-711.
    • (2002) Neuropsychopharmacology , vol.27 , pp. 699-711
    • Bymaster, F.P.1    Katner, J.S.2    Nelson, D.L.3    Hemrick-Lueke, S.K.4    Threlkeld, P.G.5    Heiligenstein, J.H.6
  • 12
    • 0033982174 scopus 로고    scopus 로고
    • A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder
    • Connor, D.F., Barkley, R.A., & Davis, H.T. (2000). A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clinical Pediatrics, 39, 15-25.
    • (2000) Clinical Pediatrics , vol.39 , pp. 15-25
    • Connor, D.F.1    Barkley, R.A.2    Davis, H.T.3
  • 13
    • 53849147672 scopus 로고    scopus 로고
    • and Company, Retrieved July 1, 2003, from
    • Eli Lilly and Company. (2003). Strattera. Retrieved July 1, 2003, from http://pi.lilly.com/us/strattera-pi.pdf
    • (2003) Strattera
    • Lilly, E.1
  • 14
    • 0032146143 scopus 로고    scopus 로고
    • DOPA decarboxylase activity in attention deficit hyperactivity disorder adults: A [fluorine-18]fluorodopa positron emission tomographic study
    • Ernst, M., Zametkin, A.J., Matochik, P.H., Jons, P.H., & Cohen, R.M. (1998). DOPA decarboxylase activity in attention deficit hyperactivity disorder adults: A [fluorine-18]fluorodopa positron emission tomographic study. Journal of Neuroscience, 18, 5901-5907.
    • (1998) Journal of Neuroscience , vol.18 , pp. 5901-5907
    • Ernst, M.1    Zametkin, A.J.2    Matochik, P.H.3    Jons, P.H.4    Cohen, R.M.5
  • 18
    • 0012101373 scopus 로고    scopus 로고
    • Retrieved June 23, 2003, from
    • National Center for Educational Statistics (2001). Dropout rates in the United States: 2000. Retrieved June 23, 2003, from http://nces.ed.gov/ pubs2002/2002114.pdf.
    • (2001) Dropout rates in the United States: 2000
  • 19
    • 53849122056 scopus 로고    scopus 로고
    • Diagnosis and treatment of attention deficit hyperactivity disorder in youth and adults
    • R.I. Shader Ed, Philadelphia: Lippincott Williams and Wilkins
    • Oesterheld, J.R., Shader, R.I., & Wender, P.H. (2003). Diagnosis and treatment of attention deficit hyperactivity disorder in youth and adults. In R.I. Shader (Ed.), Manual of psychiatric therapeutics (pp. 346-364). Philadelphia: Lippincott Williams and Wilkins.
    • (2003) Manual of psychiatric therapeutics , pp. 346-364
    • Oesterheld, J.R.1    Shader, R.I.2    Wender, P.H.3
  • 20
    • 0031459908 scopus 로고
    • Antidepressants for ADHD
    • Popper, C.W. (1992). Antidepressants for ADHD. Journal of Clinical Psychiatry, 58, (Suppl. 14), 14-29.
    • (1992) Journal of Clinical Psychiatry , vol.58 , Issue.SUPPL. 14 , pp. 14-29
    • Popper, C.W.1
  • 23
    • 0036925161 scopus 로고    scopus 로고
    • Adaptive changes related to medication treatment of ADHD: Listening to parents of children in clinical trials of a novel nonstimulant medication
    • Saylor, K.E., Buermeyer, C.M., Spencer, T.J., & Barkley, R.A. (2002). Adaptive changes related to medication treatment of ADHD: Listening to parents of children in clinical trials of a novel nonstimulant medication. Journal of Clinical Psychiatry, 63 (Suppl. 12), 23-28.
    • (2002) Journal of Clinical Psychiatry , vol.63 , Issue.SUPPL. 12 , pp. 23-28
    • Saylor, K.E.1    Buermeyer, C.M.2    Spencer, T.J.3    Barkley, R.A.4
  • 24
    • 0034940566 scopus 로고    scopus 로고
    • A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder
    • Scahill, L., Chappell, P.B., Kim, Y.S., Schultz, R.T., Katsovitch, L., Shepherd, E., et al. (2001). A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. American Journal of Psychiatry, 158, 1067-1074.
    • (2001) American Journal of Psychiatry , vol.158 , pp. 1067-1074
    • Scahill, L.1    Chappell, P.B.2    Kim, Y.S.3    Schultz, R.T.4    Katsovitch, L.5    Shepherd, E.6
  • 25
    • 0035687397 scopus 로고    scopus 로고
    • How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis
    • Schachter, H.M., Pham, B., King, J., Langford, S., & Moher, D. (2001). How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Canadian Medical Association Journal, 165, 1475-1488.
    • (2001) Canadian Medical Association Journal , vol.165 , pp. 1475-1488
    • Schachter, H.M.1    Pham, B.2    King, J.3    Langford, S.4    Moher, D.5
  • 26
    • 0038700760 scopus 로고    scopus 로고
    • Determining and achieving therapeutic targets in attention-deficit/hyperactivity disorder
    • Spencer, T. (2003). Determining and achieving therapeutic targets in attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 64, 265-276.
    • (2003) Journal of Clinical Psychiatry , vol.64 , pp. 265-276
    • Spencer, T.1
  • 28
    • 0036920803 scopus 로고    scopus 로고
    • Novel treatments for attention-deficit/hyperactivity disorder in children
    • Spencer, T., Biederman, J., Wilens, T.E., & Faraone, S.V. (2002). Novel treatments for attention-deficit/hyperactivity disorder in children. Journal of Clinical Psychiatry, 63(Suppl. 12), 16-22.
    • (2002) Journal of Clinical Psychiatry , vol.63 , Issue.SUPPL. 12 , pp. 16-22
    • Spencer, T.1    Biederman, J.2    Wilens, T.E.3    Faraone, S.V.4
  • 29
    • 0036935774 scopus 로고    scopus 로고
    • Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/ hyperactivity disorder
    • Spencer, T., Heiligenstein, J.H., Biederman, J., Faries, D.E., Kratochvil, C.J., Conners, C.K., et al. (2002). Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/ hyperactivity disorder. Journal of Clinical Psychiatry, 63, 1140-1147.
    • (2002) Journal of Clinical Psychiatry , vol.63 , pp. 1140-1147
    • Spencer, T.1    Heiligenstein, J.H.2    Biederman, J.3    Faries, D.E.4    Kratochvil, C.J.5    Conners, C.K.6
  • 30
    • 0037362361 scopus 로고    scopus 로고
    • Mechanism of action of selective NRIs: Both dopamine and norepinephrine increase in prefrontal cortex
    • Stahl, S.M. (2003). Mechanism of action of selective NRIs: Both dopamine and norepinephrine increase in prefrontal cortex. Journal of Clinical Psychiatry, 64, 230-231.
    • (2003) Journal of Clinical Psychiatry , vol.64 , pp. 230-231
    • Stahl, S.M.1
  • 31
    • 0035100341 scopus 로고    scopus 로고
    • Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder
    • Taylor, F.B., & Russo, J. (2001). Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology, 21, 223-228.
    • (2001) Journal of Clinical Psychopharmacology , vol.21 , pp. 223-228
    • Taylor, F.B.1    Russo, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.